MedMen Enterprises Inc.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedMen Enterprises, Inc. engages in the manufacture and marketing of cannabis products. It operates through the following geographical segments: California, Illinois, Nevada, Arizona, and Massachusetts. The company was founded by Adam Bierman and Andrew Modlin on May 21, 1987 and is headquartered in Boca Raton, FL.

Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2024) - The Class B Subordinate Voting Shares of MedMen Enterprises Inc. will be delisted from the CSE at market close today, May 16, 2024. MedMen Enterprises Inc. is currently suspended.

CSE Bulletin: Delist - MedMen Enterprises Inc. (MMEN)

Cannabis company MedMen Enterprises Inc (CSE:MMEN, OTCQX:MMNFF) announced late on Friday that it entered bankruptcy proceedings in Canada with about C$561.5 million in liabilities. Additionally, it said its wholly-owned California-based subsidiary MM CAN USA has been placed into receivership in the Los Angeles Superior Court, Santa Monica Division, meaning the company has effectively been ordered to liquidate its California assets.

Cannabis firm MedMen enters bankruptcy proceedings in Canada, receivership in US

Former high-flying cannabis company MedMen Enterprises Inc. filed for bankruptcy protection late Friday with about C$561.5 million ($411 million) in liabilities.

Cannabis company MedMen files for bankruptcy with about $411M in liabilities as it fortunes go up in smoke

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”), a cannabis company with subsidiaries operating across the United States, today announced that it made an assignment into bankruptcy pursuant to Canada's Bankruptcy and Insolvency Act (the “Bankruptcy Proceedings”) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the “Bankruptcy Trustee”). The Company's Chief Financial Officer, Amit Pandey, resign.

MedMen Announces Entering Bankruptcy Proceedings and Resignation of CFO and Directors

Aurora Cannabis

Canopy Growth

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration mulls over changing marijuana's Schedule 1 status and the Health and Human Services leans towards relaxing federal restrictions, a sliver of hope emerges.

Exit Now! 3 Cannabis Stocks to Sell in February 2024

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e.

MedMen Announces Management and Board Changes

MedMen Enterprises Inc.'s stock has drawn a cease-trade order as the once high-flying cannabis company has dropped from a $3 billion valuation in 2018 to near zero.

MedMen goes from height of $3B valuation to zero as stock draws cease-trade order

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company's assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce.

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company's CEO and CFO (“MCTO”) by its principal regulator, the Br.

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that it has entered into definitive agreements to sell its non-core business operations in Arizona and certain assets in Nevada to an affiliate of Mint Cannabis (“MINT Cannabis”), a private multi-state cannabis operator headquartered in Arizona. The transactions consist of the sale of MedMen's whol.

MedMen Enters into Definitive Agreements to Exit Arizona and Nevada per Announced Strategic Review, Selling Non-Core Assets to MINT Cannabis

Cronos Group

Jazz Pharmaceuticals

SNDL Inc.

AdvisorShares Pure Cannabis ETF 

The rollercoaster ride of the cannabis market has left many in the investing world dazed and confused. The sector's volatility is marked by winds of optimism followed by spells of disappointment.

Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced it expects to be late in filing its financial statements and management's discussion and analysis for the year ended July 1, 2023 (the “2023 Financial Filings”) under applicable Canadian securities laws. The Company is unable to timely file, without unreasonable effort and expense, its Annual Report on.

MedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade Order

Amplify Seymour Cannabis ETF

Grana y Montero

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Roundhill Cannabis ETF

Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.

Reasons To Be Cautiously Optimistic About Cannabis

Tilray Brands

The North American cannabis market is booming in 2023, thanks to the legalization of recreational and medical marijuana in several states and provinces. Many investors are betting on the growth potential of this industry, especially as cannabis may be moved to Schedule III from Schedule I of the Controlled Substances Act ( CSA ).

Ticking Time Bombs: 3 Cannabis Stocks to Dump Before the Damage Is Done

Curaleaf Holdings, Inc.

Leafly Holdings

Amplify Alternative Harvest ETF

The DEA is considering reclassifying cannabis from Schedule I to Schedule III, leading to a surge in cannabis stocks. Reclassification could lead to tax breaks, access to banking services, and more efficient logistics for the cannabis industry. Profitable cannabis companies, such as MariMed, Vext Science, and Green Thumb, are positioned to benefit from the industry's growth.

The Sustainability Of Cannabis Bull Run

The top marijuana stocks have emerged as lucrative possibilities in the volatile world of cannabis investments, with spectacular increases year to year. These green stock market treasures have piqued the interest of investors looking for chances in the thriving cannabis business, which shows no signs of slowing down. With the global trend of legalization and growing acceptance of marijuana for medicinal and recreational use, the cannabis sector is primed for exponential expansion in the following years, making it an appealing proposition for both rookie and seasoned traders.

Year-to-Date Winners: Top Marijuana Penny Stocks to Keep on Your Radar

Anheuser-Busch InBev

Many of the most popular cannabis stocks trade on the Nasdaq, including Canopy Growth, Tilray Brands, and SNDL. These businesses operate in the struggling Canadian pot market amid choking competition.

What Is the Nasdaq's Best Cannabis Stock?

IM Cannabis Corp

Welcome to the intriguing world of marijuana penny stocks! As we approach August 2023, the cannabis sector is witnessing rapid growth and drawing investors looking to cash in on the green revolution. Penny stock trading can be exciting and risky; therefore, it is critical to approach these investments with caution and sound risk management measures.

Top Marijuana Penny Stocks to Watch in August 2023

MedMen in 2018 became the first marijuana company to achieve a $1 billion valuation, but the company is now short on cash and is nearing collapse.

Cannabis Pioneer MedMen Names Fifth CEO In 3 Years As Company Teeters On Brink Of Collapse

MedMen Enterprises Inc. CA:MMEN, the struggling U.S. cannabis retailer, on Wednesday appointed Ellen Deutsch as its new chief executive, and said Amit Pandey would become its new chief financial officer on July 24. Deutsch succeeds interim chief executive Edward Record, who will keep serving as a non-executive member of MedMen's board, the company said.

MedMen appoints Ellen Deutsch as CEO

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. ("MedMen'' or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced the appointments of Ellen Deutsch as Chief Executive Officer, effective immediately, and Amit Pandey as Chief Financial Officer, effective July 24th. Deutsch succeeds Interim CEO Edward Record, who will now continue as a non-executive member of MedMen's Board of Directors. Deutsch has also been appoint.

MedMen Announces Ellen Deutsch as Chief Executive Officer and Amit Pandey as Chief Financial Officer

Cannabis retailer MedMen Enterprises Inc. MMEN, on Friday announced the resignation of Chief Financial Officer Ana Bowman, effective June 29. Bowman had served as CFO since 2022.

MedMen CFO Bowman resigns

LOS ANGELES--(BUSINESS WIRE)--MedMen Announces Resignation of Chief Financial Officer.

MedMen Announces Resignation of Chief Financial Officer

Do you want to know which marijuana stocks to buy in June? Last month, bipartisan United States House and Senate lawmakers revived the SAFE Banking Act, revitalizing the cannabis sector. Senator Chuck Schumer announced last week that a committee vote would occur immediately after a preliminary hearing. He also stated his intention to link judicial reform legislation to SAFE Banking.

Top Marijuana Penny Stocks Under $1 Worth Watching

Finding top marijuana stocks to buy in today's cannabis sector is easy. To further explain the current downtrend that the sector is facing is creating more buying opportunities. Right now many who invest in legal cannabis have 2 sides to it with the same end goal and that is to make money. Yet one said is being patient and reloading positions when there is a red day in preparation for when there is a recovery. The other half of the people are concerned and frustrated with how volatile the sector has become.

This is Why Marijuana Stocks Are Not Short Term Investments

News for MedMen Enterprises Inc. Stock (MMNFF)